The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
Clinical trial NCT04927416 · RECRUITING
Trial details
- NCT number
- NCT04927416
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-25
- Primary completion
- 2030-11-30
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.